Asset Management
Build Your Comparison
Side-by-side financial analysisStock Comparison
FHI vs VRTS vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
Banks - Diversified
FHI vs VRTS vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | Asset Management | Asset Management | Banks - Diversified |
| Market Cap | $4.49B | $948M | $908.57B |
| Revenue (TTM) | $1.86B | $831M | $280.33B |
| Net Income (TTM) | $399M | $138M | $57.05B |
| Gross Margin | 51.5% | 74.9% | 60.0% |
| Operating Margin | 27.4% | 17.4% | 25.9% |
| Forward P/E | 11.6x | 5.8x | 14.6x |
| Total Debt | $457M | $2.84B | $942.38B |
| Cash & Equiv. | $584M | $477M | $343.34B |
FHI vs VRTS vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Federated Hermes, I… (FHI) | 100 | 249.2 | +149.2% |
| Virtus Investment P… (VRTS) | 100 | 121.8 | +21.8% |
| JPMorgan Chase & Co. (JPM) | 100 | 345.8 | +245.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: FHI vs VRTS vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
FHI has the current edge in this matchup, primarily because of its strength in growth exposure and sleep-well-at-night.
- Rev growth 11.0%, EPS growth 58.8%
- Lower volatility, beta 0.70, Low D/E 36.2%, current ratio 41.26x
- Beta 0.70, yield 2.4%, current ratio 41.26x
VRTS is the clearest fit if your priority is income & stability and valuation efficiency.
- Dividend streak 8 yrs, beta 1.06, yield 6.6%
- PEG 0.39 vs FHI's 1.19
- Lower P/E (5.8x vs 11.6x), PEG 0.39 vs 1.19
JPM is the clearest fit if your priority is long-term compounding and bank quality.
- 481.2% 10Y total return vs FHI's 144.4%
- NIM 2.2% vs FHI's 0.5%
- Efficiency ratio 0.3% vs VRTS's 0.6% (lower = leaner)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 11.0% NII/revenue growth vs VRTS's -8.0% | |
| Value | Lower P/E (5.8x vs 11.6x), PEG 0.39 vs 1.19 | |
| Quality / Margins | Efficiency ratio 0.3% vs VRTS's 0.6% (lower = leaner) | |
| Stability / Safety | Beta 0.70 vs VRTS's 1.06, lower leverage | |
| Dividends | 6.6% yield, 8-year raise streak, vs JPM's 1.8% | |
| Momentum (1Y) | +43.1% vs VRTS's -13.2% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs VRTS's 0.6% |
FHI vs VRTS vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FHI vs VRTS vs JPM — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — FHI and JPM each lead in 2 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 337.5x VRTS's $831M. Profitability is closely matched — net margins range from 21.4% (FHI) to 16.7% (VRTS).
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $1.9B | $831M | $280.3B |
| EBITDAEarnings before interest/tax | $527M | $205M | $81.4B |
| Net IncomeAfter-tax profit | $399M | $138M | $57.0B |
| Free Cash FlowCash after capex | $307M | -$67M | $100.9B |
| Gross MarginGross profit ÷ Revenue | +51.5% | +74.9% | +60.0% |
| Operating MarginEBIT ÷ Revenue | +27.4% | +17.4% | +25.9% |
| Net MarginNet income ÷ Revenue | +21.4% | +16.7% | +20.4% |
| FCF MarginFCF ÷ Revenue | +16.5% | -8.1% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +1.6% | +10.9% | +16.0% |
Valuation Metrics
VRTS leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 7.1x trailing earnings, VRTS trades at a 56% valuation discount to JPM's 16.2x P/E. Adjusting for growth (PEG ratio), VRTS offers better value at 0.48x vs FHI's 1.19x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $4.5B | $948M | $908.6B |
| Enterprise ValueMkt cap + debt − cash | $4.4B | $3.3B | $1.51T |
| Trailing P/EPrice ÷ TTM EPS | 11.51x | 7.09x | 16.22x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.56x | 5.81x | 14.60x |
| PEG RatioP/E ÷ EPS growth rate | 1.19x | 0.48x | 0.92x |
| EV / EBITDAEnterprise value multiple | 7.82x | 16.19x | 18.52x |
| Price / SalesMarket cap ÷ Revenue | 2.48x | 1.14x | 3.25x |
| Price / BookPrice ÷ Book value/share | 3.51x | 0.95x | 2.51x |
| Price / FCFMarket cap ÷ FCF | 15.23x | — | 9.01x |
Profitability & Efficiency
FHI leads this category, winning 9 of 9 comparable metrics.
Profitability & Efficiency
FHI delivers a 29.5% return on equity — every $100 of shareholder capital generates $30 in annual profit, vs $14 for VRTS. FHI carries lower financial leverage with a 0.36x debt-to-equity ratio, signaling a more conservative balance sheet compared to VRTS's 2.74x. On the Piotroski fundamental quality scale (0–9), FHI scores 8/9 vs JPM's 5/9, reflecting strong financial health.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | +29.5% | +13.5% | +15.9% |
| ROA (TTM)Return on assets | +18.2% | +3.6% | +1.3% |
| ROICReturn on invested capital | +24.1% | +3.0% | +4.5% |
| ROCEReturn on capital employed | +26.3% | +3.7% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 5 | 5 |
| Debt / EquityFinancial leverage | 0.36x | 2.74x | 2.60x |
| Net DebtTotal debt minus cash | -$127M | $2.4B | $599.0B |
| Cash & Equiv.Liquid assets | $584M | $477M | $343.3B |
| Total DebtShort + long-term debt | $457M | $2.8B | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | 44.07x | 2.15x | 0.74x |
Total Returns (Dividends Reinvested)
JPM leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $23,548 today (with dividends reinvested), compared to $6,784 for VRTS. Over the past 12 months, FHI leads with a +43.1% total return vs VRTS's -13.2%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.7% vs VRTS's -7.1% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | +14.2% | -9.9% | +0.8% |
| 1-Year ReturnPast 12 months | +43.1% | -13.2% | +20.9% |
| 3-Year ReturnCumulative with dividends | +69.2% | -19.9% | +138.8% |
| 5-Year ReturnCumulative with dividends | +101.8% | -32.2% | +135.5% |
| 10-Year ReturnCumulative with dividends | +144.4% | +144.2% | +481.2% |
| CAGR (3Y)Annualised 3-year return | +19.2% | -7.1% | +33.7% |
Risk & Volatility
FHI leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
FHI is the less volatile stock with a 0.70 beta — it tends to amplify market swings less than VRTS's 1.06 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. FHI currently trades 98.7% from its 52-week high vs VRTS's 65.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.70x | 1.06x | 0.87x |
| 52-Week HighHighest price in past year | $59.83 | $215.06 | $338.09 |
| 52-Week LowLowest price in past year | $41.71 | $121.61 | $269.72 |
| % of 52W HighCurrent price vs 52-week peak | +98.7% | +65.8% | +96.2% |
| RSI (14)Momentum oscillator 0–100 | 67.2 | 49.8 | 72.1 |
| Avg Volume (50D)Average daily shares traded | 734K | 97K | 7.4M |
Analyst Outlook
Evenly matched — VRTS and JPM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: FHI as "Hold", VRTS as "Hold", JPM as "Buy". Consensus price targets imply 4.5% upside for JPM (target: $340) vs -4.2% for VRTS (target: $136). For income investors, VRTS offers the higher dividend yield at 6.58% vs JPM's 1.83%.
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | $57.50 | $135.67 | $339.75 |
| # AnalystsCovering analysts | 21 | 11 | 61 |
| Dividend YieldAnnual dividend ÷ price | +2.4% | +6.6% | +1.8% |
| Dividend StreakConsecutive years of raises | 3 | 8 | 15 |
| Dividend / ShareAnnual DPS | $1.40 | $9.32 | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | +5.9% | +6.3% | +3.8% |
FHI leads in 2 of 6 categories (Profitability & Efficiency, Risk & Volatility). VRTS leads in 1 (Valuation Metrics). 2 tied.
FHI vs VRTS vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is FHI or VRTS or JPM a better buy right now?
For growth investors, Federated Hermes, Inc.
(FHI) is the stronger pick with 11. 0% revenue growth year-over-year, versus -8. 0% for Virtus Investment Partners, Inc. (VRTS). Virtus Investment Partners, Inc. (VRTS) offers the better valuation at 7. 1x trailing P/E (5. 8x forward), making it the more compelling value choice. Analysts rate JPMorgan Chase & Co. (JPM) a "Buy" — based on 61 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — FHI or VRTS or JPM?
On trailing P/E, Virtus Investment Partners, Inc.
(VRTS) is the cheapest at 7. 1x versus JPMorgan Chase & Co. at 16. 2x. On forward P/E, Virtus Investment Partners, Inc. is actually cheaper at 5. 8x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Virtus Investment Partners, Inc. wins at 0. 39x versus Federated Hermes, Inc. 's 1. 19x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — FHI or VRTS or JPM?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +135. 5%, compared to -32. 2% for Virtus Investment Partners, Inc. (VRTS). Over 10 years, the gap is even starker: JPM returned +481. 2% versus VRTS's +144. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — FHI or VRTS or JPM?
By beta (market sensitivity over 5 years), Federated Hermes, Inc.
(FHI) is the lower-risk stock at 0. 70β versus Virtus Investment Partners, Inc. 's 1. 06β — meaning VRTS is approximately 53% more volatile than FHI relative to the S&P 500. On balance sheet safety, Federated Hermes, Inc. (FHI) carries a lower debt/equity ratio of 36% versus 3% for Virtus Investment Partners, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — FHI or VRTS or JPM?
By revenue growth (latest reported year), Federated Hermes, Inc.
(FHI) is pulling ahead at 11. 0% versus -8. 0% for Virtus Investment Partners, Inc. (VRTS). On earnings-per-share growth, the picture is similar: Federated Hermes, Inc. grew EPS 58. 8% year-over-year, compared to 1. 5% for JPMorgan Chase & Co.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — FHI or VRTS or JPM?
Federated Hermes, Inc.
(FHI) is the more profitable company, earning 22. 3% net margin versus 16. 7% for Virtus Investment Partners, Inc. — meaning it keeps 22. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FHI leads at 29. 5% versus 17. 4% for VRTS. At the gross margin level — before operating expenses — VRTS leads at 74. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is FHI or VRTS or JPM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Virtus Investment Partners, Inc. (VRTS) is the more undervalued stock at a PEG of 0. 39x versus Federated Hermes, Inc. 's 1. 19x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Virtus Investment Partners, Inc. (VRTS) trades at 5. 8x forward P/E versus 14. 6x for JPMorgan Chase & Co. — 8. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for JPM: 4. 5% to $339. 75.
08Which pays a better dividend — FHI or VRTS or JPM?
All stocks in this comparison pay dividends.
Virtus Investment Partners, Inc. (VRTS) offers the highest yield at 6. 6%, versus 1. 8% for JPMorgan Chase & Co. (JPM).
09Is FHI or VRTS or JPM better for a retirement portfolio?
For long-horizon retirement investors, JPMorgan Chase & Co.
(JPM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 87), 1. 8% yield, +481. 2% 10Y return). Both have compounded well over 10 years (JPM: +481. 2%, VRTS: +144. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between FHI and VRTS and JPM?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.